Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

New NIH grant will help Pennington Biomedical scientists to study metabolic diseases

A new federal grant will allow young scientists to delve into the mechanisms of emotional eating and preeclampsia and other disorders not considered "classic" metabolic diseases.

26 May 2020

3D model displays arrangement of intrinsic neurons in the rat heart

An interdisciplinary team of researchers has developed a virtual 3D heart, digitally showcasing the heart's unique network of neurons for the first time.

26 May 2020

Novel biomarkers linked to improved outcomes with immunotherapy in metastatic breast cancer

Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic breast cancer and may help to identify the patients most likely to benefit from this treatment, according to exploratory studies reported at the ESMO Breast Cancer Virtual Meeting 2020.

22 May 2020

Genetic discoveries show promise for developing new treatment targets for schizophrenia

In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.

22 May 2020

Texas A&M lab produces 3D-bioprinted bone tissue to benefit bone regeneration

Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.

19 May 2020

Did SARS-CoV-2 adapt to humans long before the index case?

A new study from Canada and the U.S. suggests that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may have already been pre-adapted to human transmission when it emerged in late 2019, which means there may be lingering populations of progenitor SARS-CoV-2 adept for human transmission and coronavirus disease (COVID-19) re-emergence. The research is published on the preprint server bioRxiv in May 2020.

19 May 2020

Roswell Park team proposes possible new strategy for treating pancreatic cancer

A possible new strategy for treating pancreatic cancer highlights the promise of collaboration between experts in both precision medicine and immunology.

18 May 2020

IDT opens new manufacturing facility to expand capacity of COVID-19 products

Integrated DNA Technologies, a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina.

From Integrated DNA Technologies 18 May 2020

Genome-wide pattern found in glioblastoma tumors predicts patients' life expectancy

For the past 70 years, the best indicator of life expectancy for a patient with glioblastoma (GBM) -- the most common and the most aggressive brain cancer -- has simply been age at diagnosis.

15 May 2020

New book demystifies the molecular biology of breast cancer

Breast cancer is known as one of the most deadly diseases among women. However, recent advancements in the imaging tools and diagnostic methods for breast cancer has improved the screening in the past few years.

15 May 2020

Study shows the combined effect of inherited and acquired mutations on cancer development

The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.

15 May 2020

Forensic Genomics to launch preview issue at annual ISHI

Forensic Genomics, a dynamic new peer-reviewed journal, will launch its preview issue at the annual International Symposium on Human Identification (ISHI) in September 2020.

15 May 2020

Adaptations to COVID-19 can be used improve other health challenges

The world is currently facing a global pandemic without precedence.

15 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

ACMG: Technical standard on CFTR variant testing updated

It has been nearly two decades since the American College of Medical Genetics and Genomics, together with the American College of Obstetricians and Gynecologists, made the landmark recommendation that cystic fibrosis (CF) become the first target of pan-ethnic universal carrier screening, with ACMG identifying a core panel of 23 pathogenic variants to be tested.

14 May 2020

Study provides new insights on mechanisms that promote cancer

Like subway com muters on a crowded train, cells generally prefer not to be packed in too tightly. In fact, they have set up mechanisms to avoid this, a phenomenon called "contact inhibition." A hallmark of cancer cells is that they lack this contact inhibition, and instead become pushy, facilitating their spread.

14 May 2020

New study investigates the effect of asymptomatic COVID-19 transmission

COVID-19's rapid spread throughout the world has been fueled in part by the virus' ability to be transmitted by people who are not showing symptoms of infection.

13 May 2020

Scientists are looking for alternate methods to predict the spread of COVID-19

With the ongoing challenges associated with large-scale testing for COVID-19--including test kit shortages, stringent testing criteria and the inherent limitations of current tracking systems on mildly symptomatic and asymptomatic populations, scientists are looking for alternate methods to boost testing in order to predict the spread of the disease.

13 May 2020

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Aiming to identify new therapeutic strategies for the aggressive hematological disease T-cell acute lymphoblastic leukemia (T-ALL), Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, along with collaborators from Princeton University, found a new drug that has therapeutic effect against T-ALL by inhibiting SHMT and is complementary to standard-of-care treatment.

12 May 2020

A comprehensive analysis of evidence-based information to help manage myopia

A new literature analysis published in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists, gives eye care practitioners (ECPs) a comprehensive analysis of evidence-based information needed to help manage myopia.

12 May 2020